Sharp Chucks and Machines Limited (NSE:SCML)
India · Delayed Price · Currency is INR 82.45
+4.20 (5.37%)
At close: Jul 30, 2025
Verve Therapeutics Revenue
In the fiscal year ending March 31, 2025, Sharp Chucks and Machines had annual revenue of 2.46B INR with 21.70% growth. Sharp Chucks and Machines had revenue of 1.10B in the half year ending March 31, 2025.
Revenue
2.46B
Revenue Growth
+21.70%
P/S Ratio
0.36
Revenue / Employee
4.48M
Employees
548
Market Cap
883.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2.46B | 437.72M | 21.70% |
| Mar 31, 2024 | 2.02B | 251.34M | 14.23% |
| Mar 31, 2023 | 1.77B | 243.71M | 16.01% |
| Mar 31, 2022 | 1.52B | 165.93M | 12.23% |
| Mar 31, 2021 | 1.36B | 224.83M | 19.87% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,729.85B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,429.39B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 639.28B |